TITLE

Attempt to sell generic version of zidovudine angers brand name company, researchers

AUTHOR(S)
Spurgeon, David
PUB. DATE
August 1992
SOURCE
CMAJ: Canadian Medical Association Journal;8/1/1992, Vol. 147 Issue 3, p332
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
35470361

 

Related Articles

  • FDA OKs First Generic Versions Of The HIV Drug AZT. Bauer, Jeff; Roman, Linda // RN;Nov2005, Vol. 68 Issue 11, p81 

    Reports on the U.S. Food and Drug Administration's approval of the first generic versions of the HIV drug zidovudine. Mechanism of action of the drug; Companies which have been cleared to market generic versions of the drug in the U.S.; Cost of the generic versions compared to the Retrovir brand.

  • Gilead Paves Way for Low-Cost Version of Sovaldi in Poor Nation.  // Chain Drug Review;10/27/2014, Vol. 36 Issue 17, p70 

    The article reports on the announcement of Gilead Sciences Inc. that it has signed a licensing agreement with seven companies in India to make generic versions of its drug sofusbivir, sold under the brand name Sovaldi, and sell it in 91 developing countries.

  • Zidovudine may sell as generic.  // Dermatology Times;Jul95, Vol. 16 Issue 7, p58 

    Reports that US Food and Drug Administration (FDA) has allowed Barr Laboratories to sell the generic version of the AIDS drug, zidovudine. Condition set by FDA.

  • Mylan launches generic sofosbuvir for treatment of hepatitis C.  // FRPT- Chemical Snapshot;5/10/2015, p14 

    The article announces the launch of the generic version of Hepatitis C drug sofosbuvir under the brand name MyHep by pharmaceutical company Mylan NV.

  • Will patent-holders' tactics forestall generic competition? Breu, Joseph // Drug Topics;Aug99 Supplement, Vol. 143 Issue 15, p16S 

    Focuses on generic competition in the United States. Brand name drugs which are due to go off patent by the year 2002 and become available for generic versions; Methods used by brand companies to ward off generic competition; Details on the battle of Schering-Plough's Claritin for patent...

  • Zocor move muddles generics strategies. Gonzalez, Gloria // Business Insurance;7/10/2006, Vol. 40 Issue 28, p1 

    The article discusses the attempt of pharmaceutical manufacturer Merck & Co. to maintain the market share of its brand-name drug Zocor. Merck decided to discount the price of Zocor to encourage its continued purchase rather than the generic offered by its competitors also known as simvastatin,...

  • Brand vs. generic drugs: Seeking sensible savings.  // Mayo Clinic Health Letter;Aug2011, Vol. 29 Issue 8, p4 

    The article presents questions and answers related to brand and generic drugs including the difference between generic drug and the brand name version, why is a generic drug cheaper, and why some drugs have not gone generic.

  • Multinational Medicines � Ensuring Drug Quality in an Era of Global Manufacturing. Okie, Susan // New England Journal of Medicine;8/20/2009, Vol. 361 Issue 8, p737 

    The article focuses on quality problems involving brand-name drugs and their generic versions and calls for the U.S. Food and Drug Administration (FDA) to deal with such problems through greater transparency. It relates the case of Missouri-based Ethex which is now under court to correct...

  • Authorized Generics Practice. Wagh, M. P.; Patel, J. S.; Baheti, D. R. // Systematic Reviews in Pharmacy;Jan2010, Vol. 1 Issue 1, p106 

    Due to lower price and same quality, a number of prescriptions have been increased for generic equivalents of branded products. After the expiration of patent life, profits for an innovator company decline due to market entry of the generic version of same active pharmaceutical ingredient. To...

  • DuPont Merck to sell generic drug line to senior management.  // Medical Marketing & Media;Aug97, Vol. 32 Issue 8, p18 

    Reports on the announcement of DuPont Merck Pharmaceutical Co. to sell its generics and multisource product lines to selected senior executives of the company. Name of the generics firm formed; Introduction of a generic version of oral Lodine(etodolac).

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics